RETAVASE® (reteplase) is a recombinant plasminogen activator which catalyzes the cleavage of endogenous plasminogen to generate plasmin. Plasmin degrades the fibrin matrix of the thrombus, exerting its thrombolytic action.
Contact us
Medical Information
To request specific medical information about RETAVASE or to report adverse events or product complaints, contact the Medical Information Department.
Adverse events may also be reported to the FDA’s MedWatch Program at 1-800-FDA-1088.
- Mail:
- Chiesi USA, Inc.
- 175 Regency Woods Place
- Suite 600
- Cary, NC 27518
- Email:
- US.Medical@chiesi.com
- Phone:
- 1-888-661-9260
- Fax:
- 1-866-443-3092
Contact Chiesi USA, Inc.
- Mail:
- Chiesi USA, Inc.
- 175 Regency Woods Place
- Suite 600
- Cary, NC 27518
- Phone:
- 1-888-466-6505